Oscar Health (NYSE:OSCR – Get Rating) was downgraded by research analysts at Bank of America from a “neutral” rating to an “underperform” rating in a research report issued on Wednesday, The Fly reports.
Separately, Morgan Stanley lowered their target price on Oscar Health from $18.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, June 9th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $9.75.
Shares of Oscar Health stock opened at $4.19 on Wednesday. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.22. The firm has a market cap of $884.12 million, a P/E ratio of -1.56 and a beta of 0.78. Oscar Health has a fifty-two week low of $4.08 and a fifty-two week high of $25.07. The business has a 50-day moving average price of $6.62 and a 200 day moving average price of $7.44.
Oscar Health (NYSE:OSCR – Get Rating) last announced its quarterly earnings data on Tuesday, May 10th. The company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.04. Oscar Health had a negative return on equity of 37.23% and a negative net margin of 22.93%. During the same period last year, the company earned ($0.98) earnings per share. As a group, equities research analysts anticipate that Oscar Health will post -2.58 earnings per share for the current year.
In related news, CFO Richard Scott Blackley sold 19,546 shares of the stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $5.01, for a total value of $97,925.46. Following the completion of the transaction, the chief financial officer now directly owns 264,307 shares of the company’s stock, valued at approximately $1,324,178.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Alessandrea C. Quane sold 11,300 shares of the stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $5.01, for a total value of $56,613.00. Following the completion of the transaction, the executive vice president now directly owns 131,018 shares of the company’s stock, valued at $656,400.18. The disclosure for this sale can be found here.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Psagot Value Holdings Ltd. Israel lifted its position in Oscar Health by 210.3% in the fourth quarter. Psagot Value Holdings Ltd. Israel now owns 2,371 shares of the company’s stock worth $4,518,000 after purchasing an additional 1,607 shares during the period. Advisor Group Holdings Inc. lifted its position in shares of Oscar Health by 116.8% during the 4th quarter. Advisor Group Holdings Inc. now owns 3,924 shares of the company’s stock valued at $30,000 after acquiring an additional 2,114 shares during the last quarter. Aquire Wealth Advisors LLC acquired a new stake in shares of Oscar Health during the 4th quarter valued at $34,000. Royal Bank of Canada lifted its position in shares of Oscar Health by 3,837.2% during the 2nd quarter. Royal Bank of Canada now owns 5,709 shares of the company’s stock valued at $123,000 after acquiring an additional 5,564 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in shares of Oscar Health during the 4th quarter valued at $47,000. Hedge funds and other institutional investors own 98.65% of the company’s stock.
Oscar Health Company Profile (Get Rating)
Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.
Recommended Stories
Receive News & Ratings for Oscar Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
